Back to Search
WILLIAM KELLY, M.D.
M.D.
Ophthalmology Physician
NPI: 1538185426IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
96011(FL)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
NEW YORK MEDICAL COLLEGE
Class of 2000
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Guidelines for submitting adverse event reports for publication.
PMID 17471601·Pharmacoepidemiol Drug Saf·2007
6-review
Compelling features of a safe medication-use system.
PMID 16849713·Am J Health Syst Pharm·2006
8-other
Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials.
PMID 19633053·Ann Oncol·2010
8-other
Revised delta34S reference values for IAEA sulfur isotope reference materials S-2 and S-3.
PMID 19288548·Rapid Commun Mass Spectrom·2009
8-other
The wisdom of Weismann: epigenetic erasure mechanisms and germ line immortality.
PMID 19556871·Cell Cycle·2009
8-other
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
PMID 19364960·J Clin Oncol·2009
3-trial
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.
PMID 19375217·Eur Urol·2009
3-trial
A C. elegans LSD1 demethylase contributes to germline immortality by reprogramming epigenetic memory.
PMID 19379696·Cell·2009
7-preclinical
Clinical and polysomnographic predictors of short-term continuous positive airway pressure compliance.
PMID 19017888·Chest·2009
8-other
Thiostrepton biosynthesis: prototype for a new family of bacteriocins.
PMID 19265401·J Am Chem Soc·2009
8-other
Epothilones: tubulin polymerization as a novel target for prostate cancer therapy.
PMID 19048010·Nat Clin Pract Oncol·2009
6-review
An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer.
PMID 19366825·Clin Cancer Res·2009
3-trial
TROG 96.01: TTBF and PSAdt as surrogates for disease specific mortality.
PMID 19655026·Update Cancer Ther·2009
8-other
Diabetes Medication Satisfaction Tool: a focus on treatment regimens.
PMID 18931098·Diabetes Care·2009
8-other
Analysis of the indanomycin biosynthetic gene cluster from Streptomyces antibioticus NRRL 8167.
PMID 19301315·Chembiochem·2009
8-other
Intramolecular cyclizations of polyketide biosynthesis: mining for a "Diels-Alderase"?
PMID 19039353·Org Biomol Chem·2008
6-review
Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
PMID 18989865·Cancer·2008
3-trial
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004.
PMID 18824434·Clin Genitourin Cancer·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1701 N FEDERAL HWY
BOCA RATON, FL 33432 - Phone
- (561) 395-5666
Quick Facts
- NPI
- 1538185426
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile